First Trust Advisors’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$224K Buy
6,625
+1,220
+23% +$48.1K ﹤0.01% 2599
2026
Q2
$208K Buy
+5,405
New +$165K ﹤0.01% 2596
2024
Q2
– Sell
-33,306
Closed -$1.08M – 2374
2024
Q1
$1.08M Sell
33,306
-4,586
-12% -$167K ﹤0.01% 1963
2023
Q4
$1.6M Buy
+37,892
New +$1.39M ﹤0.01% 1815

Other funds holding IMVT

First Trust Advisors's IMVT Position: Q3 2026 in Review

First Trust Advisors increased its Immunovant (IMVT) stake by 23% in Q3 2026, buying an estimated $48.1K and bringing the position to 6,625 shares worth $224K. The position accounts for ﹤0.01% of the portfolio, ranked #2599.

First Trust Advisors first reported a position in IMVT in Q4 2023 and has held it in 4 quarters since. The position peaked at $1.6M in Q4 2023. 232 funds tracked by Wall St. Rank hold IMVT as of Q3 2026.

  • First Trust Advisors held 6,625 shares of Immunovant worth $224K as of Q3 2026.
  • First Trust Advisors bought 1,220 Immunovant shares in Q3 2026, an estimated $48.1K.
  • Immunovant made up ﹤0.01% of First Trust Advisors's portfolio in Q3 2026, its #2599 holding.
  • First Trust Advisors first reported a position in Immunovant in Q4 2023 and has held it in 4 quarters since.
  • First Trust Advisors's Immunovant position peaked at $1.6M in Q4 2023.
  • 232 funds tracked by Wall St. Rank held Immunovant as of Q3 2026.

Based on First Trust Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.